Pulse Biosciences, Inc. (PLSE) Misses Q4 EPS by 7c

Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q4 EPS of ($0.31), $0.07 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.

You May Also Be Interested In

• BofA maintains underperform ratings on six BDC stocks
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Cytek faces $56M damages award in Beckman Coulter patent case